IDEAYA Biosciences, Inc. [•] Shares of Common Stock Underwriting AgreementIDEAYA Biosciences, Inc. • May 13th, 2019 • Pharmaceutical preparations • New York
IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
IDEAYA BIOSCIENCES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 13th, 2019 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is effective as of «Date» by and between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”), and «Indemnitee» (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and the Indemnitee covering indemnification.
IDEAYA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 13th, 2019 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of May 9, 2019, is between IDEAYA Biosciences, Inc., a Delaware corporation (the “Company”) and Yujiro Hata (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of October 29, 2015 (“Offer Letter”).
